← All stocks

Amneal Pharmaceuticals, Inc.

AMRX No buying or selling
CIK 0001723128 #1201 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

16 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Patel Tushar Bhikhubhai
10% owner
61,341,678
19.21%
$1.08B
+14.5%
Patel Chirag K.
President & Co-CEO
7,775,204
2.43%
$137.15M
+1,417%
Patel Chintu
Co-CEO
7,770,255
2.43%
$137.07M
+1,416%
Patel Gautam
Director
1,927,595
0.6036%
$34.00M
−5.9%
MEISTER PAUL M
Director
832,800
0.2608%
$14.69M
+14.4%
Konidaris Tasos
Executive Vice President & CFO
449,434
0.1407%
$7.93M
−14.8%
George Jeffrey P.
Director
344,614
0.1079%
$6.08M
+27.9%
Nark Ted C
Director
325,848
0.1020%
$5.75M
+8.3%
Yanai Shlomo
Director
320,804
0.1005%
$5.66M
+30.6%
BUCHI J KEVIN
Director
282,520
0.0885%
$4.98M
−54.3%
Shah Nikita
Executive Vice President
253,390
0.0793%
$4.47M
−13.1%
Alva Emily Peterson
Director
211,029
0.0661%
$3.72M
−15.8%
Kiely John
Director
200,252
0.0627%
$3.53M
−21.7%
BOYER ANDREW S
Executive Vice President
193,646
0.0606%
$3.42M
−24.6%
Autor Deborah M.
Director
93,660
0.0293%
$1.65M
+0.3%
Daly Jason B.
EVP, Chief Legal Officer
35,171
0.0110%
$620.42K
−38.6%
Insider
Date
Role
Action
Shares
Price
Amount
BUCHI J KEVIN
11 Sep 2026
Director
Exercised, kept
20,445
$14.45
$295.43K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 252,871
History held since 8 May 2018